⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Impact of Diverticular Disease on the Detection of Colon Adenomas

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Impact of Diverticular Disease on the Detection of Colon Adenomas

Official Title:

Study ID: NCT02057562

Interventions

Study Description

Brief Summary: Benign adenomas of the colon have the potential to degenerate and become malignant. Therefore adenomatous polyps should be detected and resected during colonoscopy. Factors like advanced age and male gender are associated with the detection of adenomas. The same epidemiological pattern can be found with regard to colon diverticula. Furthermore, western world countries report higher incidences of both colorectal carcinoma as well as diverticular disease. It is not known whether a correlation exists between both entities. Some recent data have postulated higher adenoma detection rates in patients with concomitant diverticular disease (Rondagh EJ et al. Eur J Gastroenterol Hepatol. 2011; 23:1050-5. Kieff BJ et al. Am J Gastroenterol 2004; 99: 2007-11). If a positive correlation could be found this would possibly affect recommendations regarding colonoscopy surveillance intervals for patients with and without diverticular disease. The investigators therefore plan to conduct the following trial.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Rotkreuzklinikum München, München, Deutschland, Germany

II Medizinische Klinik am Klinikum rechts der Isar der Technischen Universität München, München, Deutschland, Germany

Contact Details

Name: Peter Klare, MD

Affiliation: II. Medizinische Klinik, Klinikum rechts der Isar der Technischen Universität München, Germany

Role: PRINCIPAL_INVESTIGATOR

Name: Peter Born, Prof. Dr.

Affiliation: Innere Medizin II, Rotkreuzklinikum München, Nymphenburger Str. 163, München, Germany

Role: STUDY_CHAIR

Name: Stefan von Delius, MD

Affiliation: II. Medizinische Klinik, Klinikum rechts der Isar der Technischen Universität München, Germany

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: